Needham Initiates Coverage On Hims & Hers Health with Buy Rating, Announces Price Target of $24
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Ryan MacDonald has initiated coverage on Hims & Hers Health with a Buy rating and set a price target of $24.
August 22, 2024 | 11:01 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Needham analyst Ryan MacDonald has initiated coverage on Hims & Hers Health with a Buy rating and a price target of $24, indicating a positive outlook for the stock.
The initiation of coverage with a Buy rating and a specific price target of $24 by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100